Pain medicines like ibuprofen will be receiving new, stronger warnings from the Food and Drug Administration due to increased risk for heart attacks and strokes. This includes over the counter brands like Advil, Motrin, and Aleve.
According to a June 9 article on Nytimes.com by Sabrina Tavernise, new data shows an increased risk of heart failure for those who take these drugs, otherwise known as NSAIDS. While the change is subtle, the FDA is asking manufacturers to update their labels from the current verbiage (“may cause” increased risk), to “cause an increased risk.” Additional changes include warning consumers that the risk can occur early in treatment and may increase the longer someone is taking the drugs.
“Everyone may be at risk, even people without an underlying risk for cardiovascular disease,” says Dr. Judy Racoosin, the deputy director of the F.D.A.’s Division of Anesthesia, Analgesia and Addiction Products, in a statement.
An FDA spokesperson says the changes will affect both prescription and over the counter versions of the drug. They also said in their statement that those with heart conditions should ask their doctor before taking any NSAIDS.
[author] [author_image timthumb=’off’]http://www.drhousecallsofpv.com/wp-content/uploads/2013/02/sjlphoto1sm.jpg[/author_image] [author_info]
Steven J. Lipsky MD, FACEP has been a Board Certified Emergency Physician in Arizona for the last 37 years, and a resident of the Town of Paradise Valley for the last 36 years. Steve Lipsky on Google Plus[/author_info] [/author]